TMDX
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages TransMedics Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TMDX
NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has...
Read moreDetails
TMDX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that TransMedics Group, Inc. Investors with Substantial Losses Have Opportunity to Lead the TransMedics Class Action Lawsuit
SAN DIEGO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of...
Read moreDetails
TMDX INVESTOR UPDATE: An Investigation has been initiated on behalf of TransMedics Group, Inc. Investors – Contact BFA Law (NASDAQ:TMDX)
NEW YORK, Feb. 08, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation...
Read moreDetails
Lowey Dannenberg, P.C. is Investigating TransMedics Group, Inc. (NASDAQ:TMDX) for Potential Violations of the Federal Securities Laws
NEW YORK, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers...
Read moreDetails
TransMedics Stock Is Worth $0 According to This Short-Seller. Here’s Why I’m Not Selling.
In this video, I will talk about TransMedics (TMDX -5.16%) and the recent short-seller report. Watch the short video to...
Read moreDetails
Berman Tabacco Announces Investigation of TransMedics Group, Inc. (TMDX) Concerning Claims by Scorpion Capital
BOSTON, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Berman Tabacco announces that it is investigating potential securities law violations by TransMedics...
Read moreDetails
Why TransMedics Group Stock Is Tanking Today
Shares of TransMedics Group (TMDX -12.34%) were tanking 14.3% lower as of 10:46 a.m. ET on Friday.
Read moreDetails
TMDX ALERT: TransMedics Group, Inc. Investigated For Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm
Shares of TransMedics Group are down following an investigative report by Scorpion Capital. Block & Leviton is investigating TMDX for...
Read moreDetails
Why Transmedics Plunged in December
Shares of Transmedics (TMDX 9.47%) fell 28.1% in December, according to data from S&P Global Market Intelligence.
Read moreDetails
1 Super Growth Stock Down 63% to Buy Hand Over Fist in 2025
Leading organ transplant technology provider TransMedics (TMDX 3.90%) increased sales by more than 100% in 10 straight quarters from early...
Read moreDetails